Pricing Log in Create free account

Cue Biopharma, Inc. (CUE) vs Protara Therapeutics, Inc. (TARA)

Cue Biopharma, Inc. and Protara Therapeutics, Inc. are both Biotechnology companies. Cue Biopharma, Inc. and Protara Therapeutics, Inc. are of similar size ($141.8M and $135.6M). Protara Therapeutics, Inc. has the higher net margin (0.00% vs −435.8%) and the lower return on invested capital (−255.1% vs 0.00%). Across the 13 metrics below, Protara Therapeutics, Inc. leads on 8 and Cue Biopharma, Inc. on 5.

Valuation

Metric CUE TARA Biotechnology median
P/E n/m n/m 8.42
P/S 3.14 n/m 10.01
P/B 51.25 0.91 2.21
Price to free cash flow n/m n/m 21.01
EV/EBITDA n/m n/m 0.61
EV/Sales 2.73 n/m 9.41
Earnings yield (144.73%) (56.25%) (31.85%)
Free cash flow yield (42.34%) (45.43%) (24.58%)

Profitability

Metric CUE TARA Biotechnology median
Gross margin 100.00% 0.00% 65.16%
Operating margin (262.03%) 0.00% 0.00%
Net margin (435.83%) 0.00% 0.00%
Free cash flow margin (133.13%) 0.00% 0.00%
Return on equity (1,603.48%) (45.80%) (56.36%)
Return on assets (459.60%) (42.05%) (48.04%)
Return on invested capital 0.00% (255.06%) 0.00%

Growth

Metric CUE TARA Biotechnology median
Revenue growth (TTM) 354.37% — 6.02%
EPS growth (last fiscal year) 61.11% 38.25% 30.26%
Revenue growth, 5-year CAGR 54.16% — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CUE TARA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 1.25 10.97 4.72
Net debt to EBITDA 1.10 2.38 0.96

Dividend

Metric CUE TARA Biotechnology median
Dividend yield — — 0.08%
Payout ratio — — —

Size

Metric CUE TARA Biotechnology median
Market cap 135.63m 141.83m 132.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack